Mark your calendars for Evidentiary Considerations for Integration of Biomarkers in Drug Development, a symposium jointly sponsored by the University of Maryland Center of Excellence in Regulatory Science and Innovation, Critical Path Institute, and the Food and Drug Administration.
About the Event:
Scheduled for August 21, 2015, this one-day symposium will bring together leading scientists and researchers from industry, academia, and the Food and Drug Administration (FDA), providing a unique opportunity for participants to gain perspective on biomarker development and application of biomarkers in preclinical and clinical research. Topics to be covered include:
- An overview of biomarkers in drug development
- Biomarker qualification
- Evidentiary considersations for biomarker utilization in drug development
The symposium will be held at the University of Maryland School of Pharmacy, located at 20 N. Pine Street in Baltimore, from 9:00 a.m. to 5:00 p.m., and is open to the public. Registration is required.